Why Luis Ortiz can only blame himself after latest failed drug test

He knew he was under the radar, yet still tested positive for performance-enhancing drugs.

Luis Ortiz will likely miss out on an opportunity to fight WBC heavyweight world champion Deontay Wilder on Nov. 4, and he only blame himself for this latest mishap.

It marked the third time in 16 months that a Wilder opponent has tested positive for a banned substance.

This is not the first time that Ortiz has failed a drug test. He was stripped of the WBA’s interim title in 2014 after he tested positive for steroids following a first-round knockout of Lateef Kayode.

According to ESPN, Ortiz provided a urine sample for a random test on Sept. 22 during training camp in Miami. Ortiz’s “A” sample tested positive for the banned diuretics chlorothiazide and hydrochlorothiazide, which can be used to conceal PED use.

Ortiz and his camp shared a photo on Instagram of a prescription bottle that suggests that the positive test was a direct result of taking Losartan/HCTZ, a drug typically prescribed to treat high blood pressure and kidney disease in patients with type 2 diabetes.

But whether or not he was prescribed the medication is not the issue. Ortiz failed to obtain a TUE, otherwise known as a Therapeutic Use Exemption. In fact, per RingTV, he never even attempted to get a TUE, which is required under World Anti-Doping Agency (WADA) guidelines.

That naturally raises a lot of red flags given Ortiz’s history. Applying for a TUE and getting rejected is harmless. Not even trying to acquire a TUE and getting busted is very suspect and not to mention unprofessional.

It is completely possible that this was an innocent mistake, but ignorance is not an excuse for violating procedure.

Ultimately, Ortiz is responsible for what goes in and out of his body, and he should be held accountable for it.

Share this story

Team FightNights

must see